Show simple item record

dc.contributor.authorJOSHI, RRen_US
dc.contributor.authorRAGHUVANSHI, Men_US
dc.contributor.authorPANDYA, Pen_US
dc.date.accessioned2011-09-02T03:19:50Zen_US
dc.date.accessioned2011-12-26T12:59:56Zen_US
dc.date.accessioned2011-12-27T05:53:08Z
dc.date.available2011-09-02T03:19:50Zen_US
dc.date.available2011-12-26T12:59:56Zen_US
dc.date.available2011-12-27T05:53:08Z
dc.date.issued2006en_US
dc.identifier.citationJOURNAL OF BIOLOGICAL SYSTEMS, 14(3), 463-489en_US
dc.identifier.issn0218-3390en_US
dc.identifier.urihttp://dx.doi.org/10.1142/S0218339006001891en_US
dc.identifier.urihttp://dspace.library.iitb.ac.in/xmlui/handle/10054/12951en_US
dc.identifier.urihttp://hdl.handle.net/10054/12951
dc.description.abstractWith pulmonary drug administration gaining more and more importance, there is an obvious need for improvement in the existing methods and search for the newer ones. We have carried out the first ever study on the potentials of yagyopathy in this regard. While introducing this new mode of pulmonary drug administration, we also highlight some preliminary clinical and empirical results on drug inhalation characterization of yagyopathy that indicate its effectiveness in the treatment of pulmonary tuberculosis and thus motivate the present study. We construct mathematical models to evaluate the efficacy of this method of herbal cure vis-a-vis the common modes of oral and intravenous medication. The models are analyzed mathematically for the availability of the drug and other important pharmacokinetic features for the case when the site of infection and hence of desired activation is located in the lungs. Computer simulation experiments and validation are also carried out using available data from relevant empirical studies. The results further support significant potential of yagyopathy especially in terms of higher lung deposits, (bio) availability and residence time. The scope of yagyopathy and related research directions are discussed.en_US
dc.language.isoenen_US
dc.publisherWORLD SCIENTIFIC PUBL CO PTE LTDen_US
dc.subjectInhalationen_US
dc.subjectBioavailabilityen_US
dc.subjectDepositionen_US
dc.subjectAbsorptionen_US
dc.subject.otherYagya (Homa)en_US
dc.subject.otherPulmonary Drug Administrationen_US
dc.subject.otherMathematical Modeling For Pharmacokinetic Simulationen_US
dc.subject.otherPulmonary Tuberculosisen_US
dc.titleYagyopathy versus oral and IV drug administration: Evaluation for pulmonary tuberculosis using compartment modelingen_US
dc.typeArticleen_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record